Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-centered, Radiation Dose Escalation, Open, Exploratory, Phase 1/2a Clinical Trial on the Safety, Efficacy and Pharmacokinetic Characteristics of BNCT(Boron Neutron Capture Therapy) in Patients With Recurrent High-grade Gliomas

NCT05737212 is registered in ClinicalTrials.gov with Dawonmedax Co., Ltd. as lead sponsor.

NCT NCT05737212
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05737212 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-centered, Radiation Dose Escalation, Open, Exploratory, Phase 1/2a Clinical Trial on the Safety, Efficacy and Pharmacokinetic Characteristics of BNCT(Boron Neutron Capture Therapy) in Patients With Recurrent High-grade Gliomas
Lead sponsor
Dawonmedax Co., Ltd.
Phase
Phase 1/2
Overall status
Terminated
Start date
December 5, 2022
Completion date
June 11, 2024
Enrollment
7 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent anaplastic astrocytoma, recurrent anaplastic oligodendroglioma, recurrent glioblastoma, recurrent high-grade glioma